Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
26.92
Oct 30 • 3:59 PM ET Dollar change-0.20 Percentage change(-0.74%)
Aftermarket Close
26.92
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Oct 30, 4:35 PMPhilips launches HyperVue Integrated System in U.S., combining DeepOCT+NIRS imaging with X1-FFR coronary physiology
Index
-
Market Cap
26.31B
Enterprise Value
32.83B
Income
1.30B
Sales
20.60B
Book/sh
13.39
Cash/sh
2.09
Employees
66401
IPO
Mar 17, 1980
P/E
20.05
Forward P/E
14.27
PEG
3.30
P/S
1.28
P/B
2.01
P/C
12.86
P/FCF
11.73
EV/EBITDA
9.92
EV/Sales
1.59
Quick Ratio
0.82
Current Ratio
1.26
Debt/Eq
0.65
LT Debt/Eq
0.55
Option/Short
Yes / Yes
EPS (ttm)
1.34
EPS next Y
1.89
EPS next Q
0.39
EPS this Y
-0.38%
EPS next Y
1.85%
EPS next 5Y
4.32%
EPS past 3/5Y
- -4.98%
Sales past 3/5Y
2.42% 0.39%
EPS Y/Y TTM
266.88%
Sales Y/Y TTM
-
EPS Q/Q
62.15%
Sales Q/Q
3.10%
Insider Own
0.01%
Insider Trans
0.00%
Inst Own
5.25%
Inst Trans
-0.50%
ROA
4.21%
ROE
10.24%
ROIC
6.39%
Gross Margin
45.93%
Oper. Margin
9.12%
Profit Margin
6.30%
SMA20
5.13%
SMA50
5.48%
SMA200
-1.06%
Trades
Shs Outstand
977.43M
Shs Float
977.31M
52W High
33.44 -19.49%
52W Low
23.62 13.97%
Volatility
1.50% 1.52%
ATR (14)
0.46
RSI (14)
65.39
Beta
0.74
Rel Volume
1.30
Avg Volume
977.09K
Volume
1,273,484
Perf Week
0.11%
Perf Month
13.06%
Perf Quarter
2.63%
Perf Half Y
2.91%
Perf YTD
-0.59%
Perf Year
-1.28%
Perf 3Y
49.60%
Perf 5Y
-38.45%
Perf 10Y
-1.71%
Prev Close
27.12
Price
26.92
Change %
-0.74%
Consensus
Buy
Avg. Price Target
$29.96
Implied Upside
+11.3%
Analysts11incl. previous ratings
Rating Distribution5 Buy · 5 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 03, 2026Downgrade
UBS logoUUBS
Buy → Neutral
Dec 17, 2025Initiated
RY logoRRBC Capital Mkts
Sector Perform
Feb 25, 2025Upgrade
EExane BNP Paribas
Neutral → Outperform
Feb 20, 2025Upgrade
UBS logoUUBS
Neutral → Buy
Oct 29, 2024Upgrade
JEF logoJJefferies
Underperform → Hold
May 13, 2024Upgrade
BBernstein
Mkt Perform → Outperform
May 07, 2024Upgrade
EExane BNP Paribas
Underperform → Neutral
Apr 30, 2024Upgrade
UBS logoUUBS
Sell → Neutral
Apr 30, 2024Upgrade
JPM logoJJP Morgan
Underweight → Neutral
Feb 07, 2024Downgrade
EExane BNP Paribas
Outperform → Underperform
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
PresidentMr. Roy Willem Odilia Jakobs
Ph.D.Dr. Paulus A. Stoffels M.D.
Executive VPMs. Charlotte Hanneman
Executive VPMr. Marnix J. van Ginneken Ph.D.
Executive VP & COOMr. Willem Appelo